Cargando…

Effects of phloroglucinol on the active phase of labour (EPAL trial): a single blinded randomised controlled trial in a tertiary hospital in sub-Sahara Africa

INTRODUCTION: One of the most recognized factors of maternal and neonatal outcome pertaining to the peripartum period is the duration of labour. Finding a drug that will decrease the duration of labour with no effects on mother and foetus will be welcomed. Thereby in this study we aimed to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Tchente, Charlotte Nguefack, Nana, Theophile Njamen, Tolefac, Paul Nkemtendong, Abanda, Martin Hongieh, Angong, Francky Teddy Endomba, Tamambang, Rita Frinue, Kenfack, Gabin Ulrich, Mangala, Georges Nkwelle, Muhammad, Sagir, Doualla, Marie Solange, Belley, Eugene Priso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110543/
https://www.ncbi.nlm.nih.gov/pubmed/30167045
http://dx.doi.org/10.11604/pamj.2018.30.17.14728
_version_ 1783350493237477376
author Tchente, Charlotte Nguefack
Nana, Theophile Njamen
Tolefac, Paul Nkemtendong
Abanda, Martin Hongieh
Angong, Francky Teddy Endomba
Tamambang, Rita Frinue
Kenfack, Gabin Ulrich
Mangala, Georges Nkwelle
Muhammad, Sagir
Doualla, Marie Solange
Belley, Eugene Priso
author_facet Tchente, Charlotte Nguefack
Nana, Theophile Njamen
Tolefac, Paul Nkemtendong
Abanda, Martin Hongieh
Angong, Francky Teddy Endomba
Tamambang, Rita Frinue
Kenfack, Gabin Ulrich
Mangala, Georges Nkwelle
Muhammad, Sagir
Doualla, Marie Solange
Belley, Eugene Priso
author_sort Tchente, Charlotte Nguefack
collection PubMed
description INTRODUCTION: One of the most recognized factors of maternal and neonatal outcome pertaining to the peripartum period is the duration of labour. Finding a drug that will decrease the duration of labour with no effects on mother and foetus will be welcomed. Thereby in this study we aimed to evaluate the effects of phloroglucinol on the duration of the active phase of labour. METHODS: We did a single blinded placebo controlled randomised 1:1 parallel designed superiority trial between January and June 2017 in Douala general hospital. Participants greater than 18 years with singleton uncomplicated pregnancy who consented following randomisation, were administered either 80mg/8ml intravenous phloroglucinol or 8ml of sterile water when in active labour. The primary outcome was the duration of labour. Modified intention to treat analysis was done with the level of significance set at a p value of 0.05. RESULTS: 122 participants received the intervention. The mean total duration labour in the treatment and placebo group were 216.8 ± 38.7 and 358.5 ± 65.8 respectively (p value = 0.243). The mean duration of the active phase of labour in the treatment and placebo group were 183.0±35.6 and 316.0±52.2 respectively (p value = 0.046). The mean rate of cervical dilatation in the treatment and placebo group were 2.1 ± 0.4 and 1.3 ± 0.4 respectively (p value = 0.322). There was no difference in maternal and foetal outcomes between the two groups. CONCLUSION: Phloroglucinol shortens the duration of active phase of labour by about 2 hours (42%). It is safe to mother and baby and does not cause adverse foetal or maternal outcomes.
format Online
Article
Text
id pubmed-6110543
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher The African Field Epidemiology Network
record_format MEDLINE/PubMed
spelling pubmed-61105432018-08-30 Effects of phloroglucinol on the active phase of labour (EPAL trial): a single blinded randomised controlled trial in a tertiary hospital in sub-Sahara Africa Tchente, Charlotte Nguefack Nana, Theophile Njamen Tolefac, Paul Nkemtendong Abanda, Martin Hongieh Angong, Francky Teddy Endomba Tamambang, Rita Frinue Kenfack, Gabin Ulrich Mangala, Georges Nkwelle Muhammad, Sagir Doualla, Marie Solange Belley, Eugene Priso Pan Afr Med J Research INTRODUCTION: One of the most recognized factors of maternal and neonatal outcome pertaining to the peripartum period is the duration of labour. Finding a drug that will decrease the duration of labour with no effects on mother and foetus will be welcomed. Thereby in this study we aimed to evaluate the effects of phloroglucinol on the duration of the active phase of labour. METHODS: We did a single blinded placebo controlled randomised 1:1 parallel designed superiority trial between January and June 2017 in Douala general hospital. Participants greater than 18 years with singleton uncomplicated pregnancy who consented following randomisation, were administered either 80mg/8ml intravenous phloroglucinol or 8ml of sterile water when in active labour. The primary outcome was the duration of labour. Modified intention to treat analysis was done with the level of significance set at a p value of 0.05. RESULTS: 122 participants received the intervention. The mean total duration labour in the treatment and placebo group were 216.8 ± 38.7 and 358.5 ± 65.8 respectively (p value = 0.243). The mean duration of the active phase of labour in the treatment and placebo group were 183.0±35.6 and 316.0±52.2 respectively (p value = 0.046). The mean rate of cervical dilatation in the treatment and placebo group were 2.1 ± 0.4 and 1.3 ± 0.4 respectively (p value = 0.322). There was no difference in maternal and foetal outcomes between the two groups. CONCLUSION: Phloroglucinol shortens the duration of active phase of labour by about 2 hours (42%). It is safe to mother and baby and does not cause adverse foetal or maternal outcomes. The African Field Epidemiology Network 2018-05-09 /pmc/articles/PMC6110543/ /pubmed/30167045 http://dx.doi.org/10.11604/pamj.2018.30.17.14728 Text en © Charlotte Nguefack Tchente et al. http://creativecommons.org/licenses/by/2.0/ The Pan African Medical Journal - ISSN 1937-8688. This is an Open Access article distributed under the terms of the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Tchente, Charlotte Nguefack
Nana, Theophile Njamen
Tolefac, Paul Nkemtendong
Abanda, Martin Hongieh
Angong, Francky Teddy Endomba
Tamambang, Rita Frinue
Kenfack, Gabin Ulrich
Mangala, Georges Nkwelle
Muhammad, Sagir
Doualla, Marie Solange
Belley, Eugene Priso
Effects of phloroglucinol on the active phase of labour (EPAL trial): a single blinded randomised controlled trial in a tertiary hospital in sub-Sahara Africa
title Effects of phloroglucinol on the active phase of labour (EPAL trial): a single blinded randomised controlled trial in a tertiary hospital in sub-Sahara Africa
title_full Effects of phloroglucinol on the active phase of labour (EPAL trial): a single blinded randomised controlled trial in a tertiary hospital in sub-Sahara Africa
title_fullStr Effects of phloroglucinol on the active phase of labour (EPAL trial): a single blinded randomised controlled trial in a tertiary hospital in sub-Sahara Africa
title_full_unstemmed Effects of phloroglucinol on the active phase of labour (EPAL trial): a single blinded randomised controlled trial in a tertiary hospital in sub-Sahara Africa
title_short Effects of phloroglucinol on the active phase of labour (EPAL trial): a single blinded randomised controlled trial in a tertiary hospital in sub-Sahara Africa
title_sort effects of phloroglucinol on the active phase of labour (epal trial): a single blinded randomised controlled trial in a tertiary hospital in sub-sahara africa
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110543/
https://www.ncbi.nlm.nih.gov/pubmed/30167045
http://dx.doi.org/10.11604/pamj.2018.30.17.14728
work_keys_str_mv AT tchentecharlottenguefack effectsofphloroglucinolontheactivephaseoflabourepaltrialasingleblindedrandomisedcontrolledtrialinatertiaryhospitalinsubsaharaafrica
AT nanatheophilenjamen effectsofphloroglucinolontheactivephaseoflabourepaltrialasingleblindedrandomisedcontrolledtrialinatertiaryhospitalinsubsaharaafrica
AT tolefacpaulnkemtendong effectsofphloroglucinolontheactivephaseoflabourepaltrialasingleblindedrandomisedcontrolledtrialinatertiaryhospitalinsubsaharaafrica
AT abandamartinhongieh effectsofphloroglucinolontheactivephaseoflabourepaltrialasingleblindedrandomisedcontrolledtrialinatertiaryhospitalinsubsaharaafrica
AT angongfranckyteddyendomba effectsofphloroglucinolontheactivephaseoflabourepaltrialasingleblindedrandomisedcontrolledtrialinatertiaryhospitalinsubsaharaafrica
AT tamambangritafrinue effectsofphloroglucinolontheactivephaseoflabourepaltrialasingleblindedrandomisedcontrolledtrialinatertiaryhospitalinsubsaharaafrica
AT kenfackgabinulrich effectsofphloroglucinolontheactivephaseoflabourepaltrialasingleblindedrandomisedcontrolledtrialinatertiaryhospitalinsubsaharaafrica
AT mangalageorgesnkwelle effectsofphloroglucinolontheactivephaseoflabourepaltrialasingleblindedrandomisedcontrolledtrialinatertiaryhospitalinsubsaharaafrica
AT muhammadsagir effectsofphloroglucinolontheactivephaseoflabourepaltrialasingleblindedrandomisedcontrolledtrialinatertiaryhospitalinsubsaharaafrica
AT douallamariesolange effectsofphloroglucinolontheactivephaseoflabourepaltrialasingleblindedrandomisedcontrolledtrialinatertiaryhospitalinsubsaharaafrica
AT belleyeugenepriso effectsofphloroglucinolontheactivephaseoflabourepaltrialasingleblindedrandomisedcontrolledtrialinatertiaryhospitalinsubsaharaafrica